After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed

Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that involve young children, experts from an FDA advisory panel expressed their frustration at being unable to draw conclusions about the safety and effectiveness of the shots and said more testing is needed.